Skip to Content
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2016 ($M)
  • Previous Rank
  • Morning Consult Brand Index

The health insurer–the fifth largest in the U.S.–agreed last year to be acquired by its rival Anthem for $48.4 billion. The move should give the combined company greater scale and help it cut costs, something that is sorely needed, particularly now as the Affordable Care Act has eaten into profits across the industry. While Cigna, like its peers, has had to deal with high medical expenses from its newly insured customers since the health care law went into effect, the impact on the company has been minimal: Cigna’s individual health plans, which were sold on ObamaCare exchanges in eight states in 2015, only represent 1% of its total medical insurance company’s customers. Although the company’s CEO said late last year that it hasn’t made any money on its ACA business so far, Cigna’s profits only declined very slightly in 2015, and its revenues rose 8.5%. It is still waiting on U.S. regulators to approve its deal with Anthem, and it is unclear how long that will take, given increased federal scrutiny of M&A.

Company Info

David M. Cordani
Health Care
Health Care: Insurance and Managed Care
HQ Location
Bloomfield, CT
Years on Fortune 500 List22
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$37,8768.5%
Profits ($M)$2,094-0.4%
Assets ($M)$57,088-
Total Stockholder Equity ($M)$12,035-
Market Value — as of March 31, 2016 ($M)$35,101-

Profit Ratios

Profit as % of Revenues5.5%
Profits as % of Assets3.7%
Profits as % of Stockholder Equity17.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)8.04
EPS % Change (from 2014)2.7%
EPS % Change (5 year annual rate)10.5%
EPS % Change (10 year annual rate)6.8%

Total Return

Total Return to Investors (2015)42.2%
Total Return to Investors (5 year, annualized)32%
Total Return to Investors (10 year, annualized)14.8%